Mathilde Aubertin
A5034962973- Acute Ischemic Stroke Management
- Stroke Rehabilitation and Recovery
- Cerebrovascular and Carotid Artery Diseases
- Vascular Malformations Diagnosis and Treatment
- Intracranial Aneurysms: Treatment and Complications
- Traumatic Brain Injury and Neurovascular Disturbances
- Pharmacology and Obesity Treatment
- Intracerebral and Subarachnoid Hemorrhage Research
- Venous Thromboembolism Diagnosis and Management
- Retinal and Optic Conditions
- Cerebrospinal fluid and hydrocephalus
- Inflammatory mediators and NSAID effects
- Vascular Tumors and Angiosarcomas
- Human Health and Disease
- Analytical Methods in Pharmaceuticals
- Meningioma and schwannoma management
- Diabetes Management and Research
- Medical and Biological Sciences
- Vascular Malformations and Hemangiomas
- Peripheral Artery Disease Management
Assistance Publique – Hôpitaux de Paris
2021-2025
Hôpital Lariboisière
2024-2025
Fondation de Rothschild
2020-2024
Sorbonne Université
2021
Fondation Ophtalmologique Adolphe de Rothschild
2021
Pitié-Salpêtrière Hospital
2021
Endovascular embolization of brain arteriovenous malformations (AVMs) is sometimes intentionally partial, in the case staged treatment for instance. Residual AVMs may be prone to angioarchitectural modification during follow-up. The objective this work evaluate nature and extent these modifications.
Mechanical thrombectomy (MT) is the standard of care for patients with anterior circulation large vessel occlusion. Early neurological improvement (ENI), defined as a reduction ≥ 8 on National Institutes Health Stroke Scale (NIHSS) compared baseline score, or an NIHSS score 0 1 at 24 h after MT, strong predictor 3-month favorable outcome in such patients. The impact ENI MT stroke basilar artery occlusion (BAO) not clear. We aimed to study effects BAO.We performed retrospective analysis...
In the settings of thrombectomy, first-pass effect (FPE), defined by a complete recanalization after one pass with no rescue therapy, has been shown to be associated an improved outcome. As this phenomenon predominantly described in anterior circulation strokes, we aimed study prevalence, outcomes, and predictors FPE patients basilar artery occlusion.From prospective multicentric registry, collected data all consecutive occlusion who underwent thrombectomy compared outcomes achieved those...
Patients with acute basilar artery occlusion (BAO) and low-to-moderate symptoms (National Institutes of Health Stroke Scale [NIHSS] < 10) are poorly represented in thrombectomy trials. Our objective is to compare best medical management (BMT) this population.
Background When standard endovascular thrombectomy techniques fail to achieve a successful recanalization, it is often necessary use rescue therapies (RTs). RTs are more commonly used in basilar artery occlusions and conventionally thought represent “a last resort option.” We sought study the outcomes of occlusion patients who received RT, further hypothesize that number instrumental passes before initiation RT may be associated with increased risk for poor clinical outcomes. Methods...
The natural history of unruptured intracranial aneurysms (UIAs) in Western populations is still debated, especially for those <7 mm. Reporting data a large single-center cohort managed with watchful waiting therefore interesting.From January 2011 to June 2019, 662 UIAs were followed up by yearly MR angiography. Morphologically stable conservatively while unstable offered treatment. patients' clinical and radiological analyzed retrospectively.UIAs ≤4 mm 60%, 4.1-7.0 33%, >7 7%. They located...
Intranidal direct arteriovenous (AV) shunts are rarely observed in brain malformations (bAVMs).1 The endovascular treatment of such AV may be challenging. Indeed, there is a significant risk venous migration the embolic agent used to occlude shunt, leading subsequent nidus bleeding due impairment (slowdown or even occlusion) bAVM’s drainage.2 Various techniques have been developed avoid inopportune drainage during attempts intranidal shunt.3–5 We present this Technical Video (video 1)...
Background: Hematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). Objective: To compare conventional revised hematoma (HE), while accounting WOC. Methods: We analyzed data from the ATACH-2 trial, comparing incorporating intraventricular hemorrhage (IVH) to “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale 4-6 at...